Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status

Journal of breast cancer
Jihye ChoiHyun-Ah Kim

Abstract

Phosphorylated ribosomal S6 kinase 1 (pS6K1) is a major downstream regulator of the mammalian target of rapamycin (mTOR) pathway. Recent studies have addressed the role of S6K1 in adipogenesis. pS6K1 may affect the outcome of estrogen depletion therapy in patients with hormone-sensitive breast cancer due to its association with adipogenesis and increased local estrogen levels. This study aimed to investigate the potential of pS6K1 as a predictive marker of adjuvant aromatase inhibitor (AI) therapy outcome in postmenopausal or ovarian function-suppressed patients with hormone-sensitive breast cancer. Medical records were retrospectively reviewed in postmenopausal or ovarian function-suppressed patients with estrogen receptor-positive and node-positive primary breast cancer. pS6K1 expression status was scored on a scale from 0 (negative) to 3+ (positive) based on immunohistochemical analysis. A total of 428 patients were eligible. The median follow-up duration was 44 months (range, 1-90). In patients with positive pS6K1 expression, AIs significantly improved disease-free survival (DFS) compared to selective estrogen receptor modulators (SERMs) (5 year-DFS: 83.5% vs. 50.7%, p = 0.016). However, there was no benefit of AIs on DFS i...Continue Reading

References

Apr 1, 1997·The Journal of Steroid Biochemistry and Molecular Biology·N Harada
Aug 26, 1998·The Journal of Steroid Biochemistry and Molecular Biology·A M Brodie, V C Njar
Aug 3, 2000·Journal of the National Cancer Institute·M BärlundA Kallioniemi
Dec 31, 2005·The New England Journal of Medicine·UNKNOWN Breast International Group (BIG) 1-98 Collaborative GroupAron Goldhirsch
Sep 19, 2006·American Journal of Surgery·Jennifer R GarreauNathalie Johnson
Apr 18, 2009·Endocrinology·Margot P Cleary, Michael E Grossmann
May 25, 2010·Developmental Cell·Larissa S CarnevalliSara C Kozma
Feb 22, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G VialeUNKNOWN BIG 1-98 Collaborative and International Breast Cancer Study Groups
Dec 16, 2011·Trends in Endocrinology and Metabolism : TEM·Serdar E BulunHong Zhao
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N Lynn HenryAnna Maria Storniolo
Jun 13, 2012·Breast Cancer Research and Treatment·Caitlin C MurphySally W Vernon
Apr 29, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D S M ChanT Norat
Apr 14, 2016·Journal of Molecular Endocrinology·Hong ZhaoSerdar E Bulun
Jul 22, 2016·BMB Reports·Sang Ah YiJeung-Whan Han
Aug 25, 2016·The New England Journal of Medicine·Béatrice Lauby-SecretanUNKNOWN International Agency for Research on Cancer Handbook Working Group
Dec 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sao Jiralerspong, Pamela J Goodwin
Mar 11, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·William J GradisharDorothy A Shead
Aug 2, 2018·Frontiers of Medicine·Ning JiangJing Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
bilateral oophorectomy
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.